These emerging treatments , including Semaglutide , belong to a class of drugs called GLP-1 agents. Primarily developed for managing diabetes mellitus , they work by assisting the pancreas to secrete more insulin and reducing high sugar levels. Additionally , their potential to encourage weight management has resulted to substantial attention and c